Eric D. Routh

985 total citations
15 papers, 699 citations indexed

About

Eric D. Routh is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Eric D. Routh has authored 15 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Immunology. Recurrent topics in Eric D. Routh's work include DNA and Nucleic Acid Chemistry (7 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Eric D. Routh is often cited by papers focused on DNA and Nucleic Acid Chemistry (7 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Eric D. Routh collaborates with scholars based in United States, Switzerland and New Zealand. Eric D. Routh's co-authors include James P. Vaughn, Steven D. Creacy, Steven A. Akman, Yoshikuni Nagamine, Philip J. Smaldino, Guangxu Jin, Lance D. Miller, Jeff W. Chou, Ashok Pullikuth and Michael A. Black and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Eric D. Routh

15 papers receiving 694 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric D. Routh United States	8	497	191	112	85	81	15	699
Davide Schiavone Italy	11	470 0.9×	124 0.6×	63 0.6×	71 0.8×	14 0.2×	12	570
Jayanthi Gudikote United States	11	454 0.9×	72 0.4×	32 0.3×	48 0.6×	42 0.5×	15	531
Yiyi Liang China	11	224 0.5×	197 1.0×	75 0.7×	155 1.8×	59 0.7×	16	414
Breege V. Howley United States	14	581 1.2×	171 0.9×	83 0.7×	354 4.2×	43 0.5×	22	739
Debipriya Das United Kingdom	7	397 0.8×	108 0.6×	44 0.4×	46 0.5×	34 0.4×	9	488
Paolo Fardin Italy	11	231 0.5×	104 0.5×	232 2.1×	223 2.6×	35 0.4×	18	541
Paul D. Cao United States	10	615 1.2×	96 0.5×	38 0.3×	335 3.9×	65 0.8×	10	741
Alysia R. Bryll United States	6	378 0.8×	105 0.5×	55 0.5×	70 0.8×	33 0.4×	6	527
Miguel Vizoso Spain	10	410 0.8×	74 0.4×	35 0.3×	113 1.3×	52 0.6×	15	499
Martijn Koppens Netherlands	8	344 0.7×	127 0.7×	40 0.4×	64 0.8×	33 0.4×	11	428

Countries citing papers authored by Eric D. Routh

Since Specialization

Citations

This map shows the geographic impact of Eric D. Routh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric D. Routh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric D. Routh more than expected).

Fields of papers citing papers by Eric D. Routh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric D. Routh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric D. Routh. The network helps show where Eric D. Routh may publish in the future.

Co-authorship network of co-authors of Eric D. Routh

This figure shows the co-authorship network connecting the top 25 collaborators of Eric D. Routh. A scholar is included among the top collaborators of Eric D. Routh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric D. Routh. Eric D. Routh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Routh, Eric D., et al.. (2023). Evaluation of tumor antigen-specific antibody responses in patients with metastatic triple negative breast cancer treated with cyclophosphamide and pembrolizumab. Journal for ImmunoTherapy of Cancer. 11(3). e005848–e005848. 4 indexed citations

Routh, Eric D., Amanda E.D. Van Swearingen, Maria J. Sambade, et al.. (2022). Comprehensive Analysis of the Immunogenomics of Triple-Negative Breast Cancer Brain Metastases From LCCC1419. Frontiers in Oncology. 12. 818693–818693. 6 indexed citations

Routh, Eric D., et al.. (2022). Prognostic attributes of immune signatures in soft tissue sarcomas show differential dependencies on tumor mutational burden. Cancer. 128(17). 3254–3264. 2 indexed citations

Pullikuth, Ashok, Eric D. Routh, Kip D. Zimmerman, et al.. (2021). Bulk and Single-Cell Profiling of Breast Tumors Identifies TREM-1 as a Dominant Immune Suppressive Marker Associated With Poor Outcomes. Frontiers in Oncology. 11. 734959–734959. 22 indexed citations

Green, Katelyn M., Amy Krans, Michael Reisinger, et al.. (2021). The RNA helicase DHX36–G4R1 modulates C9orf72 GGGGCC hexanucleotide repeat–associated translation. Journal of Biological Chemistry. 297(2). 100914–100914. 28 indexed citations

Routh, Eric D., Ashok Pullikuth, Guangxu Jin, et al.. (2020). Transcriptomic Features of T Cell-Barren Tumors Are Conserved Across Diverse Tumor Types. Frontiers in Immunology. 11. 57–57. 10 indexed citations

Reisinger, Michael, Joshua D. Tompkins, Arthur D. Riggs, et al.. (2020). G-Quadruplex Helicase DHX36/G4R1 Engages Nuclear Lamina Proteins in Quiescent Breast Cancer Cells. ACS Omega. 5(38). 24916–24926. 2 indexed citations

Thomas, Alexandra, Eric D. Routh, Ashok Pullikuth, et al.. (2018). Tumor mutational burden is a determinant of immune-mediated survival in breast cancer. OncoImmunology. 7(10). e1490854–e1490854. 209 indexed citations

Pullikuth, Ashok, Julia Chifman, Eric D. Routh, et al.. (2018). Abstract 3791: Triggering receptor expressed in myeloid cells 1 (TREM1) is a predictive marker for breast cancer therapeutics. Cancer Research. 78(13_Supplement). 3791–3791. 1 indexed citations

10.

Routh, Eric D., et al.. (2017). A G-quadruplex DNA-affinity Approach for Purification of Enzymatically Active G4 Resolvase1. Journal of Visualized Experiments. 5 indexed citations

11.

Routh, Eric D., et al.. (2017). A G-quadruplex DNA-affinity Approach for Purification of Enzymatically Active G4 Resolvase1. Journal of Visualized Experiments. 2 indexed citations

12.

Smaldino, Philip J., Eric D. Routh, Jung H. Kim, et al.. (2015). Mutational Dissection of Telomeric DNA Binding Requirements of G4 Resolvase 1 Shows that G4-Structure and Certain 3’-Tail Sequences Are Sufficient for Tight and Complete Binding. PLoS ONE. 10(7). e0132668–e0132668. 14 indexed citations

13.

Giri, Banabihari, Philip J. Smaldino, Steven D. Creacy, et al.. (2011). G4 Resolvase 1 tightly binds and unwinds unimolecular G4-DNA. Nucleic Acids Research. 39(16). 7161–7178. 78 indexed citations

14.

Creacy, Steven D., et al.. (2008). G4 Resolvase 1 Binds Both DNA and RNA Tetramolecular Quadruplex with High Affinity and Is the Major Source of Tetramolecular Quadruplex G4-DNA and G4-RNA Resolving Activity in HeLa Cell Lysates. Journal of Biological Chemistry. 283(50). 34626–34634. 159 indexed citations

15.

Vaughn, James P., et al.. (2005). The DEXH Protein Product of the DHX36 Gene Is the Major Source of Tetramolecular Quadruplex G4-DNA Resolving Activity in HeLa Cell Lysates. Journal of Biological Chemistry. 280(46). 38117–38120. 157 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact